Agios Pharmaceuticals (AGIO) Shares Outstanding (2012 - 2026)

Agios Pharmaceuticals (AGIO) has 15 years of Shares Outstanding (Entity) data on file, last reported at $59.5 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 2.69% year-over-year to $59.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $59.5 million (up 2.69% YoY) and the FY2025 annual result came in at $58.0 million, up 2.05% from the prior year.
• Shares Outstanding (Entity) rose to $59.5 million in Q2 2026, from $58.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $59.5 million in Q2 2026 to a low of $54.6 million in Q1 2022.
• A 5-year average of $56.6 million and a median of $56.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) fell 22.16% — and 2026, when it rose 2.69%.
• Tracing AGIO's Shares Outstanding (Entity) over 5 years: stood at $54.8 million in 2022, then rose by 1.57% to $55.7 million in 2023, then increased by 2.08% to $56.8 million in 2024, then grew by 2.05% to $58.0 million in 2025, then increased by 2.62% to $59.5 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $59.5 million (Q2 2026), $58.8 million (Q1 2026), and $58.0 million (Q4 2025), per Business Quant data.